510(k) DEN200072

Lumipulse G ß-Amyloid Ratio (1-42/1-40) by Fujirebio Diagnostics,Inc. — Product Code QSE

DEN200072 is an FDA 510(k) premarket notification submitted by Fujirebio Diagnostics,Inc. for the device "Lumipulse G ß-Amyloid Ratio (1-42/1-40)". The FDA issued a decision of De Novo granted on May 4, 2022. The device falls under product code QSE (Alzheimer’S Disease Pathology Assessment Test), a Class II device regulated under 21 CFR 866.5840. Fujirebio Diagnostics,Inc. has 44 other 510(k) clearances on record.

Clearance details

Decision
DENG (De Novo granted)
Decision Date
May 4, 2022
Date Received
Nov 20, 2020
Clearance Type
Direct
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Alzheimer’S Disease Pathology Assessment Test
Device Class
Class II
Regulation Number
866.5840
Review Panel
IM
Submission Type
510(k)

In vitro test to determine whether a patient presenting with cognitive impairment and being evaluated for AD and other causes of cognitive decline will test positive or negative for amyloid plaques or neurofibrillary tangles as measured by PET imaging agents.

Need the full FDA record for Fujirebio Diagnostics,Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for DEN200072. Report a data issue: hello@regdatalab.com.